Renal arterial resistive index, monocyte chemotactic protein 1 and neutrophil gelatinase-associated lipocalin, for predicting acute kidney injury in critically ill cancer patients.
Bertha M Córdova-SánchezSilvio A Ñamendys-SilvaIrlanda Pacheco-BravoFrancisco Javier García-GuillénJuan Manuel Mejía-ViletCristino CruzGustavo Barraza-AguirreWalter Oswaldo Ramírez-TalaveraAdán R López-ZamoraFernando Monera-MartínezLuis Jesús Vidal-ArellanoLuis Eduardo Morales-BuenrostroPublished in: International urology and nephrology (2023)
The RRI, uMCP-1, and uNGAL have a similar ability to predict AKI. The RRI is more specific, while urine biomarkers are more sensitive to predict stage 3 AKI. The RRI correlates with hemodynamic variables. The novel uMCP-1 could be a useful biomarker that needs to be extensively studied.